{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T10:42:26Z","timestamp":1784544146308,"version":"3.55.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2016\/13778-8"],"award-info":[{"award-number":["2016\/13778-8"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.bcp.2020.114121","type":"journal-article","created":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T20:48:50Z","timestamp":1593031730000},"page":"114121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["TNF-\u03b1 inhibition decreases MMP-2 activity, reactive oxygen species formation and improves hypertensive vascular hypertrophy independent of its effects on blood pressure"],"prefix":"10.1016","volume":"180","author":[{"given":"B.R.","family":"Mattos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.F.","family":"Bonacio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.R.","family":"Vitorino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.T.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.H.","family":"Amaral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Dellalibera-Joviliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.C.","family":"Franca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.E.","family":"Tanus-Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Rizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2020.114121_b0005","first-page":"808353","article-title":"Pathophysiology of vascular remodeling in hypertension","volume":"2013","author":"Renna","year":"2013","journal-title":"Int. J. Hypertens."},{"key":"10.1016\/j.bcp.2020.114121_b0010","doi-asserted-by":"crossref","unstructured":"A.C. Montezano, A. Nguyen Dinh Cat, F.J. Rios, R.M. Touyz, Angiotensin II and vascular injury, Curr. Hypertens. Rep. 16(6) (2014) 431.","DOI":"10.1007\/s11906-014-0431-2"},{"issue":"5","key":"10.1016\/j.bcp.2020.114121_b0015","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1161\/01.ATV.0000069907.12357.7E","article-title":"Inflammation and vascular hypertrophy induced by angiotensin II: role of NADPH oxidase-derived reactive oxygen species independently of blood pressure elevation?","volume":"23","author":"Schiffrin","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.bcp.2020.114121_b0020","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/s41467-017-01629-7","article-title":"Regulation of angiotensin II actions by enhancers and super-enhancers in vascular smooth muscle cells","volume":"8","author":"Das","year":"2017","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.bcp.2020.114121_b0025","doi-asserted-by":"crossref","first-page":"e0138372","DOI":"10.1371\/journal.pone.0138372","article-title":"Tumor necrosis factor - alpha is essential for angiotensin II-induced ventricular remodeling: role for oxidative stress","volume":"10","author":"Sriramula","year":"2015","journal-title":"PLoS ONE"},{"issue":"9","key":"10.1016\/j.bcp.2020.114121_b0030","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s11906-019-0971-6","article-title":"Adaptive immunity in hypertension","volume":"21","author":"Mikolajczyk","year":"2019","journal-title":"Curr. Hypertens. Rep."},{"issue":"5","key":"10.1016\/j.bcp.2020.114121_b0035","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1161\/HYPERTENSIONAHA.107.102152","article-title":"Involvement of tumor necrosis factor-alpha in angiotensin II-mediated effects on salt appetite, hypertension, and cardiac hypertrophy","volume":"51","author":"Sriramula","year":"2008","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.bcp.2020.114121_b0040","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/FJC.0000000000000316","article-title":"Pentoxifylline ameliorates cardiac fibrosis, pathological hypertrophy, and cardiac dysfunction in angiotensin II-induced hypertensive rats","volume":"67","author":"Zhang","year":"2016","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"12","key":"10.1016\/j.bcp.2020.114121_b0045","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.1172\/JCI90699","article-title":"TNF regulates transcription of NLRP3 inflammasome components and inflammatory molecules in cryopyrinopathies","volume":"127","author":"McGeough","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2020.114121_b0050","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.freeradbiomed.2015.05.015","article-title":"c-Jun N-terminal kinase attenuates TNFalpha signaling by reducing Nox1-dependent endosomal ROS production in vascular smooth muscle cells","volume":"86","author":"Choi","year":"2015","journal-title":"Free Radic. Biol. Med."},{"issue":"5","key":"10.1016\/j.bcp.2020.114121_b0055","doi-asserted-by":"crossref","first-page":"e63847","DOI":"10.1371\/journal.pone.0063847","article-title":"Inhibition of TNF in the brain reverses alterations in RAS components and attenuates angiotensin II-induced hypertension","volume":"8","author":"Sriramula","year":"2013","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.bcp.2020.114121_b0060","first-page":"6","article-title":"Pentoxifyline inhibits angiotensin II-induced proliferation in rat vascular smooth muscle cells","volume":"26","author":"Han","year":"2015","journal-title":"Biomed. Res."},{"issue":"4","key":"10.1016\/j.bcp.2020.114121_b0065","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000441621","article-title":"Matrix metalloproteinase 2 as a potential mediator of vascular smooth muscle cell migration and chronic vascular remodeling in hypertension","volume":"52","author":"Belo","year":"2015","journal-title":"J. Vasc. Res."},{"issue":"10","key":"10.1016\/j.bcp.2020.114121_b0070","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.2174\/1568026611208011214","article-title":"Novel therapeutic approaches targeting matrix metalloproteinases in cardiovascular disease","volume":"12","author":"Briasoulis","year":"2012","journal-title":"Curr. Top. Med. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2020.114121_b0075","doi-asserted-by":"crossref","first-page":"241","DOI":"10.23736\/S0031-0808.17.03321-3","article-title":"Heart failure and role of circulating MMP-2 and MMP-9","volume":"59","author":"Radosinska","year":"2017","journal-title":"Panminerva Med."},{"key":"10.1016\/j.bcp.2020.114121_b0080","doi-asserted-by":"crossref","first-page":"699","DOI":"10.2741\/3274","article-title":"Activation of MMP-2 as a key event in oxidative stress injury to the heart","volume":"14","author":"Schulz","year":"2009","journal-title":"Front. Biosci."},{"issue":"5","key":"10.1016\/j.bcp.2020.114121_b0085","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00204-008-0363-1","article-title":"Evidence of early involvement of matrix metalloproteinase-2 in lead-induced hypertension","volume":"83","author":"Rizzi","year":"2009","journal-title":"Arch. Toxicol."},{"issue":"5","key":"10.1016\/j.bcp.2020.114121_b0090","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1742-7843.2010.00656.x","article-title":"Doxycycline dose-dependently inhibits MMP-2-mediated vascular changes in 2K1C hypertension","volume":"108","author":"Guimaraes","year":"2011","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"9","key":"10.1016\/j.bcp.2020.114121_b0095","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.freeradbiomed.2009.02.011","article-title":"Antioxidant treatment reduces matrix metalloproteinase-2-induced vascular changes in renovascular hypertension","volume":"46","author":"Castro","year":"2009","journal-title":"Free Radic. Biol. Med."},{"issue":"2","key":"10.1016\/j.bcp.2020.114121_b0100","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1476-5381.2011.01360.x","article-title":"Pyrrolidine dithiocarbamate down-regulates vascular matrix metalloproteinases and ameliorates vascular dysfunction and remodelling in renovascular hypertension","volume":"164","author":"Cau","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2020.114121_b0105","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1476-5381.2010.00678.x","article-title":"Spironolactone and hydrochlorothiazide exert antioxidant effects and reduce vascular matrix metalloproteinase-2 activity and expression in a model of renovascular hypertension","volume":"160","author":"Ceron","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.bcp.2020.114121_b0110","doi-asserted-by":"crossref","first-page":"C779","DOI":"10.1152\/ajpcell.00398.2003","article-title":"Angiotensin II-induced MMP-2 release from endothelial cells is mediated by TNF-alpha","volume":"286","author":"Arenas","year":"2004","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"4","key":"10.1016\/j.bcp.2020.114121_b0115","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s40618-014-0209-z","article-title":"Pentoxifylline alleviates hypertension in metabolic syndrome: effect on low-grade inflammation and angiotensin system","volume":"38","author":"Azhar","year":"2015","journal-title":"J. Endocrinol. Invest."},{"issue":"7","key":"10.1016\/j.bcp.2020.114121_b0120","doi-asserted-by":"crossref","first-page":"e40065","DOI":"10.1371\/journal.pone.0040065","article-title":"Etanercept, a widely used inhibitor of tumor necrosis factor-alpha (TNF-alpha), prevents retinal ganglion cell loss in a rat model of glaucoma","volume":"7","author":"Roh","year":"2012","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.bcp.2020.114121_b0125","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1161\/01.HYP.0000168925.98963.ef","article-title":"Chronic tumor necrosis factor-alpha inhibition enhances NO modulation of vascular function in estrogen-deficient rats","volume":"46","author":"Arenas","year":"2005","journal-title":"Hypertension"},{"issue":"11","key":"10.1016\/j.bcp.2020.114121_b0130","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jash.2017.09.007","article-title":"Pentoxifylline treatment enhances antihypertensive activity of captopril through hemorheological improvement in spontaneously hypertensive rats during development of arterial hypertension","volume":"11","author":"Plotnikov","year":"2017","journal-title":"J. Am. Soc. Hypertens."},{"issue":"6","key":"10.1016\/j.bcp.2020.114121_b0135","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1536\/ihj.15-203","article-title":"Pentoxifylline prevents driamycin-induced myocardial fibrosis and apoptosis in rats","volume":"56","author":"Zang","year":"2015","journal-title":"Int Heart J"},{"issue":"1\u20132","key":"10.1016\/j.bcp.2020.114121_b0140","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11010-009-0136-z","article-title":"Chronic etanercept treatment prevents the development of hypertension in fructose-fed rats","volume":"330","author":"Tran","year":"2009","journal-title":"Mol. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.bcp.2020.114121_b0145","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00380-018-1228-z","article-title":"Determination of the Th1, Th2, Th17, and Treg cytokine profile in patients with chronic Chagas heart disease and systemic arterial hypertension","volume":"34","author":"Bestetti","year":"2019","journal-title":"Heart Vessels"},{"issue":"3","key":"10.1016\/j.bcp.2020.114121_b0150","first-page":"485","article-title":"Kinins and cytokines in plasma and cerebrospinal fluid of patients with neuropsychiatric lupus","volume":"30","author":"Dellalibera-Joviliano","year":"2003","journal-title":"J. Rheumatol."},{"issue":"2","key":"10.1016\/j.bcp.2020.114121_b0155","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.atherosclerosis.2007.10.011","article-title":"Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats","volume":"198","author":"Castro","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bcp.2020.114121_b0160","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.freeradbiomed.2018.11.002","article-title":"Nitrite treatment downregulates vascular MMP-2 activity and inhibits vascular remodeling in hypertension independently of its antihypertensive effects","volume":"130","author":"Rizzi","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bcp.2020.114121_b0165","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.redox.2015.06.009","article-title":"Consistent antioxidant and antihypertensive effects of oral sodium nitrite in DOCA-salt hypertension","volume":"5","author":"Amaral","year":"2015","journal-title":"Redox Biol."},{"issue":"4","key":"10.1016\/j.bcp.2020.114121_b0170","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.matbio.2012.01.009","article-title":"Time course involvement of matrix metalloproteinases in the vascular alterations of renovascular hypertension","volume":"31","author":"Ceron","year":"2012","journal-title":"Matrix Biol."},{"issue":"3","key":"10.1016\/j.bcp.2020.114121_b0175","doi-asserted-by":"crossref","DOI":"10.3390\/mps2030061","article-title":"An inexpensive staining alternative for gelatin zymography gels","volume":"2","author":"Wechselberger","year":"2019","journal-title":"Methods Protoc."},{"issue":"2","key":"10.1016\/j.bcp.2020.114121_b0180","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1742-7843.2011.00698.x","article-title":"Consistent alterations of circulating matrix metalloproteinases levels in untreated hypertensives and in spontaneously hypertensive rats: a relevant pharmacological target","volume":"109","author":"Fontana","year":"2011","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.bcp.2020.114121_b0185","article-title":"Tempol inhibits TGF-beta and MMPs upregulation and prevents cardiac hypertensive changes","author":"Rizzi","year":"2011","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.bcp.2020.114121_b0190","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1146\/annurev.pharmtox.47.120505.105230","article-title":"Intracellular targets of matrix metalloproteinase-2 in cardiac disease: rationale and therapeutic approaches","volume":"47","author":"Schulz","year":"2007","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"5","key":"10.1016\/j.bcp.2020.114121_b0195","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1089\/jir.2008.0076","article-title":"IL-1beta augments TNF-alpha-mediated inflammatory responses from lung epithelial cells","volume":"29","author":"Saperstein","year":"2009","journal-title":"J. Interferon Cytokine Res."},{"issue":"3","key":"10.1016\/j.bcp.2020.114121_b0200","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.niox.2012.01.009","article-title":"Doxycycline ameliorates 2K\u20131C hypertension-induced vascular dysfunction in rats by attenuating oxidative stress and improving nitric oxide bioavailability","volume":"26","author":"Castro","year":"2012","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.bcp.2020.114121_b0205","doi-asserted-by":"crossref","first-page":"916310","DOI":"10.4061\/2011\/916310","article-title":"Oxidative stress and vascular damage in hypertension: role of angiotensin II","volume":"2011","author":"Virdis","year":"2011","journal-title":"Int J Hypertens"},{"issue":"10","key":"10.1016\/j.bcp.2020.114121_b0210","doi-asserted-by":"crossref","first-page":"F1231","DOI":"10.1152\/ajprenal.00557.2012","article-title":"Tumor necrosis factor-alpha: regulation of renal function and blood pressure","volume":"304","author":"Ramseyer","year":"2013","journal-title":"Am. J. Physiol. Renal. Physiol."},{"issue":"4","key":"10.1016\/j.bcp.2020.114121_b0215","doi-asserted-by":"crossref","first-page":"F1005","DOI":"10.1152\/ajprenal.00535.2016","article-title":"Tumor necrosis factor-alpha, kidney function, and hypertension","volume":"313","author":"Mehaffey","year":"2017","journal-title":"Am. J. Physiol. Renal. Physiol."},{"issue":"7","key":"10.1016\/j.bcp.2020.114121_b0220","doi-asserted-by":"crossref","first-page":"F1031","DOI":"10.1152\/ajprenal.00024.2013","article-title":"Protective role of the endothelial isoform of nitric oxide synthase in ANG II-induced inflammatory responses in the kidney","volume":"305","author":"Whiting","year":"2013","journal-title":"Am. J. Physiol. Renal. Physiol."},{"issue":"3","key":"10.1016\/j.bcp.2020.114121_b0225","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1161\/01.HYP.0000198545.01860.90","article-title":"Tumor necrosis factor alpha blockade increases renal Cyp2c23 expression and slows the progression of renal damage in salt-sensitive hypertension","volume":"47","author":"Elmarakby","year":"2006","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.bcp.2020.114121_b0230","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/S0002-9440(10)64445-8","article-title":"Immunosuppressive treatment protects against angiotensin II-induced renal damage","volume":"161","author":"Muller","year":"2002","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.bcp.2020.114121_b0235","first-page":"285","article-title":"Kinetics of beneficial effect of pentoxifylline on persistent forms of arterial hypertension","volume":"18","author":"McHedlishvili","year":"1998","journal-title":"Clin. Hemorheol. Microcirc."},{"issue":"6","key":"10.1016\/j.bcp.2020.114121_b0240","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1172\/JCI123462","article-title":"RhoBTB1 protects against hypertension and arterial stiffness by restraining phosphodiesterase 5 activity","volume":"129","author":"Mukohda","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.bcp.2020.114121_b0245","doi-asserted-by":"crossref","first-page":"F474","DOI":"10.1152\/ajprenal.00376.2016","article-title":"Phosphodiesterase 5 inhibition ameliorates angiotensin II-dependent hypertension and renal vascular dysfunction","volume":"312","author":"Thieme","year":"2017","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"10.1016\/j.bcp.2020.114121_b0250","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/s12967-014-0250-x","article-title":"Inhibition of phosphodiesterase 5 restores endothelial function in renovascular hypertension","volume":"12","author":"Dias","year":"2014","journal-title":"J. Transl. Med."},{"issue":"3","key":"10.1016\/j.bcp.2020.114121_b0255","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1081\/JDI-120021159","article-title":"Combination of pentoxifylline with angiotensin converting enzyme inhibitors produces an additional reduction in microalbuminuria in hypertensive type 2 diabetic patients","volume":"25","author":"Harmankaya","year":"2003","journal-title":"Ren. Fail."},{"key":"10.1016\/j.bcp.2020.114121_b0260","article-title":"Effects of adding pentoxifylline to captopril on primary hypertension: a pilot randomized clinical trial","author":"Namdar","year":"2019","journal-title":"J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.bcp.2020.114121_b0265","doi-asserted-by":"crossref","first-page":"F1055","DOI":"10.1152\/ajprenal.90439.2008","article-title":"Temporal analysis of signaling pathways activated in a murine model of two-kidney, one-clip hypertension","volume":"297","author":"Cheng","year":"2009","journal-title":"Am. J. Physiol. Renal. Physiol."},{"issue":"1","key":"10.1016\/j.bcp.2020.114121_b0270","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s11906-000-0066-3","article-title":"Oxidative stress and vascular damage in hypertension","volume":"2","author":"Touyz","year":"2000","journal-title":"Curr. Hypertens. Rep."},{"issue":"7","key":"10.1016\/j.bcp.2020.114121_b0275","doi-asserted-by":"crossref","first-page":"F1031","DOI":"10.1152\/ajprenal.00024.2013","article-title":"Protective role of the endothelial isoform of nitric oxide synthase in ANG II-induced inflammatory responses in the kidney","volume":"305","author":"Whiting","year":"2018","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"10.1016\/j.bcp.2020.114121_b0280","doi-asserted-by":"crossref","first-page":"154836","DOI":"10.1016\/j.cyto.2019.154836","article-title":"Interplay of TNF-alpha, soluble TNF receptors and oxidative stress in coronary chronic total occlusion of the oldest patients with coronary heart disease","volume":"125","author":"Li","year":"2019","journal-title":"Cytokine"},{"issue":"10","key":"10.1016\/j.bcp.2020.114121_b0285","doi-asserted-by":"crossref","first-page":"e46568","DOI":"10.1371\/journal.pone.0046568","article-title":"Interaction of TNF with angiotensin II contributes to mitochondrial oxidative stress and cardiac damage in rats","volume":"7","author":"Mariappan","year":"2012","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.bcp.2020.114121_b0290","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.yjmcc.2006.03.007","article-title":"Salvianolic acid B from Salvia miltiorrhiza inhibits tumor necrosis factor-alpha (TNF-alpha)-induced MMP-2 upregulation in human aortic smooth muscle cells via suppression of NAD(P)H oxidase-derived reactive oxygen species","volume":"41","author":"Zhang","year":"2006","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"7","key":"10.1016\/j.bcp.2020.114121_b0295","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1161\/hc3401.093154","article-title":"Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor","volume":"104","author":"Sivasubramanian","year":"2001","journal-title":"Circulation"},{"issue":"3\u20135","key":"10.1016\/j.bcp.2020.114121_b0300","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0171-2985(11)80356-6","article-title":"Inhibition of endogenous TNF formation by pentoxifylline","volume":"187","author":"Zabel","year":"1993","journal-title":"Immunobiology"},{"issue":"9","key":"10.1016\/j.bcp.2020.114121_b0305","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1182\/blood-2004-07-2729","article-title":"Tumor necrosis factor-alpha-dependent expression of phosphodiesterase 2: role in endothelial hyperpermeability","volume":"105","author":"Seybold","year":"2005","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.bcp.2020.114121_b0310","doi-asserted-by":"crossref","first-page":"570","DOI":"10.2337\/diabetes.47.4.570","article-title":"The phosphodiesterase inhibitors pentoxifylline and rolipram prevent diabetes in NOD mice","volume":"47","author":"Liang","year":"1998","journal-title":"Diabetes"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295220303579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295220303579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:07:37Z","timestamp":1762096057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295220303579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":62,"alternative-id":["S0006295220303579"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2020.114121","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TNF-\u03b1 inhibition decreases MMP-2 activity, reactive oxygen species formation and improves hypertensive vascular hypertrophy independent of its effects on blood pressure","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2020.114121","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114121"}}